Patient Guide: IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 13 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05365659
Status: 🟢 Enrolling Now
Condition: B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, B-cell Lymphoma
Phase: PHASE1

Find a Study Location Near You

This study is available at 13 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Baltimore, Maryland
  • • Westmead, New South Wales
  • • Adelaide, South Australia
  • • And 10 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas - Join Clinical Trial NCTNCT05365659

How to Join This Clinical Trial - NCTNCT05365659

Learn how to participate in this PHASE1 trial studying an investigational therapy for B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, B-cell Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, B-cell Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, B-cell Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05365659 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 13 locations. Find a study site near you:

Clinical Research Site

Baltimore, Maryland 21201 - United States

Status: WITHDRAWN

Clinical Research Site

Westmead, New South Wales 2145 - Australia

Status: RECRUITING

Clinical Research Site

Adelaide, South Australia - Australia

Status: RECRUITING

Clinical Research Site

Hobart, Tasmania 7000 - Australia

Status: RECRUITING

Clinical Research Site

Perth, Western Australia - Australia

Status: RECRUITING

Clinical Research Site

Montreal, Quebec H3T 1E2 - Canada

Status: RECRUITING

Clinical Research Site

Candiolo, - Italy

Status: RECRUITING

Clinical Research Site

Milan, - Italy

Status: RECRUITING

Clinical Research Site

Milan, - Italy

Status: RECRUITING

Clinical Research Site

Milan, - Italy

Status: RECRUITING

And 3 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, B-cell Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation